| Assay Method Information | |
| | Inhibition of SARS-CoV-2 PLpro by SARS-CoV PLpro Inhibitors |
| Description: | Emulating Ratia et al., who detailed the potency of these four compounds against SARS-CoV-1, we utilized the peptide-AMC substrate concentration of 50 μM.3 The most potent of these four proved to be GRL-0617 with an IC50 of 2.4 μM, followed by compound 6 with a low micromolar IC50 of 5.0 μM toward SARS-CoV-2. |
| Affinity data for this assay | |
|---|---|
| If you find an error in this entry please send us an E-mail | |